3,863 reports of this reaction
2.3% of all CLOPIDOGREL BISULFATE reports
#5 most reported adverse reaction
DIARRHOEA is the #5 most commonly reported adverse reaction for CLOPIDOGREL BISULFATE, manufactured by Apotex Corp.. There are 3,863 FDA adverse event reports linking CLOPIDOGREL BISULFATE to DIARRHOEA. This represents approximately 2.3% of all 168,674 adverse event reports for this drug.
Patients taking CLOPIDOGREL BISULFATE who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is a less commonly reported adverse event for CLOPIDOGREL BISULFATE, but still significant enough to appear in the safety profile.
In addition to diarrhoea, the following adverse reactions have been reported for CLOPIDOGREL BISULFATE:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 3,863 FDA reports for CLOPIDOGREL BISULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 2.3% of all adverse event reports for CLOPIDOGREL BISULFATE, making it a notable side effect.
If you experience diarrhoea while taking CLOPIDOGREL BISULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.